Results 171 to 180 of about 16,628 (221)

Impact of Disease-Modifying Antirheumatic Drugs on Cognitive Function in Older Adults with Rheumatoid Arthritis. [PDF]

Drugs Aging
Fazel SD, Carollo M, Tap L, Spini A, Trifirò G, Mattace-Raso FUS.   +5 more
europepmc   +1 more source

Latent Tuberculosis Infection in Inflammatory Rheumatic Diseases Before Biological and Synthetic DMARD Treatment: Results from Three Rheumatology Centers in Different Regions of Türkiye. [PDF]

Thorac Res Pract
Kahveci A, Akleylek C, Batıbay S.
europepmc   +1 more source

MiR-146/TNF-α/IL-6/osteocalcin crosstalk in anti-rheumatic potential of Galleria mellonella hemolymph from computational molecular modeling to in-vivo validation. [PDF]

J Comput Aided Mol Des
Ahmed SM, Ali E, Ali AR, Mohamed MA, Abdelhafez HM, Mashaal A.   +5 more
europepmc   +1 more source

Clinical Response to Adalimumab Therapy and Its Determinants in Patients With Radiographic Axial Spondyloarthritis: A Prospective Real-World Study in Taiwan. [PDF]

Int J Rheum Dis
Liu FC, Lu CH, Kuo CF, Liao HT, Lee SS, Su KY, Sung WY, Tsai WC, Chen HH, Chen HA, Wei JC, Tseng JC, Weng MY, Chen HC, Hsieh SC.   +14 more
europepmc   +1 more source

Long-Standing Untreated or Inadequately Treated Seropositive Rheumatoid Arthritis in the Golden Age of Disease-Modifying Antirheumatic Drugs. [PDF]

Cureus
Arcilla CK, Kaeley GS, Thway M.
europepmc   +1 more source

Role of High Serum Tenascin C Levels as Potential Biomarker of Persistent Inflammation in Patients with Ankylosing Spondylitis Despite Treatment with cs-DMARDS or Anti-TNF Agents. [PDF]

Diagnostics (Basel)
Martelli-Garcia A, Esparza-Guerrero Y, Jacobo-Cuevas H, Saldaña-Cruz AM, Gonzalez-Montoya NG, Nava-Valdivia CA, Gomez-Ramirez EE, Vazquez-Villegas ML, Ponce-Guarneros JM, Ramirez-Villafaña M, Rodriguez-Jimenez NA, Rocha-Muñoz AD, Cardona-Muñoz EG, Morales-Romero J, Gonzalez-Lopez L, Gamez-Nava JI, Group for the Assessment of Prognosis Biomarkers in Autoimmune Disorders.   +16 more
europepmc   +1 more source

Impact of seropositivity and disease-modifying antirheumatic drugs on pulmonary tuberculosis risk in rheumatoid arthritis. [PDF]

ERJ Open Res
Choi H, Eun Y, Han K, Jung JH, Jung W, Kim H, Shin DW, Lee H.   +7 more
europepmc   +1 more source

[Local antirheumatic agents].

Terapevticheskii arkhiv, 1990
openaire   +1 more source